PROPECIA

The information on this site is intended for healthcare professionals in the United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
MERCK
PROPECIA® (finasteride) 1mg This site is intended only for healthcare professionals of the United States,
its territories, and Puerto Rico. Non-US residents click here
PROPECIA Packaging
Home Prescribing Information Patient Product Information Patient Website
Product Data and Highlights
Prescribing PROPECIA
PROPECIA Overview
Prescribing Information
Patient Product Information
Timeline for Results
When to Start Treatment
Resources
5-Year Data
See the results of the longest reported controlled clinical study of male pattern hair loss.
View study results.
 
  • 9636003
  • PROPECIA® (Finasteride)

Who should NOT take PROPECIA?

  • PROPECIA is for the treatment of male pattern hair loss in MEN ONLY and should not be taken by women (see A warning about PROPECIA and pregnancy).
  • PROPECIA should not be taken by children.
  • Anyone allergic to any of the ingredients.

A warning about PROPECIA and pregnancy.

  • Women who are or may potentially be pregnant:
    • – must not use PROPECIA
    • – should not handle crushed or broken tablets of PROPECIA.

If a woman who is pregnant with a male baby absorbs the active ingredient in PROPECIA, either by swallowing or through the skin, it may cause abnormalities of a male baby’s sex organs. If a woman who is pregnant comes into contact with the active ingredient in PROPECIA, a doctor should be consulted. PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.


    PROPECIA is a registered trademark of Merck & Co., Inc.
20751783(2)-07/07-PRP